test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LRMRLarimar Therapeutics Inc
Recent Activity
1.72%
$5.823M
889,000 shares@ $6.55 avg price
EOLSEvolus Inc
Recent Activity
New Position
1.7%
$5.751M
355,000 shares@ $16.2 avg price
ESTAEstablishment Labs Hldgs Inc
Recent Activity
New Position
1.67%
$5.668M
131,000 shares@ $43.27 avg price
RXSTRxsight Inc
Recent Activity
New Position
1.63%
$5.536M
112,000 shares@ $49.43 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Increased 16%
1.54%
$5.212M
58,000 shares@ $89.87 avg price
SKYESkye Bioscience Inc
Recent Activity
Decreased -2.58%
1.52%
$5.142M
1.315M shares@ $3.92 avg price
XTNTXtant Med Hldgs Inc
Recent Activity
1.48%
$5.013M
7.415M shares@ $0.68 avg price
CAPRCapricor Therapeutics Inc
Recent Activity
New Position
1.28%
$4.335M
285,000 shares@ $15.21 avg price
LUNGPulmonx Corp
Recent Activity
New Position
1.23%
$4.145M
500,000 shares@ $8.29 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
New Position
1.19%
$4.023M
195,000 shares@ $20.63 avg price